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Glomerular hemodynamic changes associated with arteriolar
lesions and tubulointerstitial inflammation.
Glomerular hemodynamic adaptations to loss of renal mass
are thought to be the initiating factor of progression to renal
failure; however, tubulointerstitial (TI) injury correlates better
with progression than with glomerular damage. Thus, it is con-
ceivable that tubulointerstitial alterations participate in the
pathophysiology of renal disease progression by modifying the
adaptive responses of glomerular hemodynamics.
In experimental models of progressive renal disease, sup-
pressing tubulointerstitial inflammatory cell infiltration with
anti-inflammatory drugs reduces renal damage despite persis-
tence of systemic hypertension. In recent studies in rats with
subtotal renal ablation, we found that treatment with polysul-
phate pentosan (PPS) and with mycophenolate mofetil (MMF)
prevented proteinuria, glomerular hypertension, and hyperfil-
tration, despite persisting arterial hypertension due to higher
afferent resistance. In addition, arteriolopathy was significantly
attenuated by MMF, suggesting preservation of vascular struc-
ture and function.
Association of vascular injury of afferent arterioles, glomeru-
lar hemodynamic changes, and renal lesions has been described
in other conditions such as hyperuricemia, protein overload,
fawn-hooded rats, and aging spontaneously hypertensive rats
(SHR).
Arteriolopathy results in a maladaptive function that permits
the transmission of systemic hypertension to glomerular capil-
laries. Glomerular hypertension results in mechanical damage
to the capillary wall and increased filtration of proteins to
tubular lumen. Enhanced tubular reabsorption induces synthe-
sis of proinflammatory and profibrotic factors, resulting in tubu-
lointerstitial inflammation and fibrosis. In conditions in which
there is overactivity of the renin-angiotensin system (RAS),
such as mild hyperuricemia and protein overload, arteriolopa-
thy is associated with increased glomerular pressure and re-
duced glomerular plasma flow that results in post-glomerular
ischemia and tubulointerstitial injury.
Key words: glomerular hypertension, arteriolopathy, inflammation, tu-
bulointerstitial injury.
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Most chronic nephropathies are characterized by pro-
gressive renal failure. The first unifying hypothesis de-
scribing the nature of this condition suggested that sur-
viving nephrons activate hemodynamic changes in order
to preserve renal function that ultimately causes struc-
tural damage in a self-perpetuating circle [1]. More re-
cently, numerous studies established that hypertension
and proteinuria play an important role during the pro-
gression of renal failure [2–4]. In fact, therapies that
lower blood pressure and reduce proteinuria effectively
retard progression, especially drugs that interfere with
the effects of the renin- angiotensin system (RAS) [5–9].
In experimental animals, a reduction of renal mass re-
sults in glomerular hypertension and hyperfiltration of the
remnant nephrons in an attempt of preserve whole kidney
function, but causes, in the long term, the development of
glomerulosclerosis [1]. In addition, the rise in glomerular
pressure alters glomerular permeability to proteins, which
in turn are filtered in excessive quantities to the tubular
lumen [2, 7, 10]. The secondary process of reabsorption
of increased amounts of filtered proteins can initiate
renal interstitial injury by activating proinflammatory
and profibrotic factors that result in infiltration of inflam-
matory cells [10], tubular ischemia, oxidative stress [11],
and epithelial mesenchymal transdifferentiation [12], which
eventually lead to tubulointerstitial fibrosis. The inflamma-
tory process contributes to renal injury even when the
initiating insult is not mediated by immunologic factors
such as the renal lesions associated with overactivity of
the RAS [13, 14], subtotal renal ablation [15–17], mild
hyperuricemia [18], protein overload [19–24], and other
experimental models. It has been shown that glomerular
hemodynamic disturbances may lead to glomerulosclerosis;
however, the rate of progression of renal failure correlates
better with the severity and extension of the tubulointersti-
tial injury than with glomerular damage [25–27]. One of
the mechanisms thought to account for these findings is
the development of atubular nephrons [28, 29]. However,
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the possibility that tubulointerstitial inflammation partic-
ipates in the pathophysiology of renal disease progres-
sion by modifying the adaptive responses of glomerular
hemodynamics has not received attention.
Tubulointerstitial injury and glomerular
hemodynamics in subtotal renal ablation
Recent studies in rats with extensive renal ablation
evaluated the role of inflammation by suppressing inflam-
matory cells infiltration with different drugs [15–17, 30–33].
In several studies, administration of mycophenolate mo-
fetil (MMF), an immunosuppressive drug that exerts a
selective antiproliferative activity on activated B and T
cells and inhibits glycosylation of adhesion molecules [34],
prevented lymphocyte and macrophage proliferation and
infiltration and reduced progressive renal damage [15–17,
32]. In every study the beneficial effects of MMF treat-
ment occurred despite the persistence of systemic hyper-
tension, and in some studies regardless of proteinuria,
suggesting that renal protection was not mediated by
amelioration of glomerular hemodynamic disturbances
[15, 17, 32]. Fujihara et al [15] measured glomerular
capillary pressure (Pgc) and found that the rise in glo-
merular pressure was not changed after 4 weeks of MMF
therapy. However, after 8 weeks, when rats had consider-
ably higher values of glomerular pressure, MMF therapy
was associated with partial reduction of Pgc and protein-
uria [15]. On the other hand, treatment with pentoxyfil-
line, an anti-inflammatory drug that blocks nuclear factor
kappa B (NF-B), activation also reduced proteinuria
and renal damage independent of changes in blood pres-
sure, suggesting preservation of glomerular function [33].
Thus, although the renal protective effect of interrupting
the inflammatory process by different maneuvers is well
established, it is still controversial if these maneuvers
also prevent the glomerular hemodynamic disturbances.
In this regard we recently studied if the prevention of
renal injury by suppression of the inflammatory process
in subtotal renal ablation rats could be partially due to
improvement in glomerular hypertension and hyperfil-
tration in remnant nephrons [31]. We treated 5/6 ne-
phrectomy (Nx) rats with polysulphate pentosan (PPS), a
heparinoid with anti-inflammatory effects. Polysulphate
pentosan prevented proteinuria, reduced inflammatory
cell infiltration, and significantly attenuated renal injury.
Glomerular function in remnant nephrons was character-
ized by hyperfiltration, increased plasma flow, and glo-
merular hypertension due to inability of the afferent
arteriole to prevent the transmission of systemic hyper-
tension to glomerular tuft. Polysulphate pentosan treat-
ment prevented glomerular hypertension and hyperfil-
tration despite persisting arterial hypertension, due to a
rise in afferent arteriolar resistance [31]. These results
suggested that suppression of inflammation reduced vas-
cular injury and improved arteriolar functional capacity.
To further test this hypothesis we designed a study
in which we evaluated the effects of suppressing the
inflammatory process with MMF on glomerular hemody-
namics, arteriolar structural changes, and renal histologic
injury in the same model of chronic renal failure [35].
Treatment with MMF suppressed inflammatory cells in-
filtration without decreasing arterial pressure. Despite
persistent arterial hypertension, glomerular pressure was
normalized, glomerular hyperfiltration was reduced sub-
stantially, and the rise in glomerular plasma flow was
significantly attenuated due to a higher afferent resis-
tance. Arteriolar structural changes evaluated by mor-
phometry with image computer analysis in 5/6 Nx rats
showed hypertrophy of afferent arteriolar wall evidenced
by a significant increase of media/lumen ratio, which
was significantly attenuated by MMF treatment. These
results suggested that preservation of vascular structure
was associated with preserved vascular function as indi-
cated by a higher afferent resistance [35]. Although other
authors have proposed that beneficial effects of MMF
are independent of glomerular function, they have used
different strains of rats [15, 17] and more importantly,
lower doses of MMF [15, 17, 32]. Thus, it is conceivable
that a lesser immunosuppressive effect was insufficient
to prevent arteriolopathy and to normalize glomerular
hemodynamics.
Tubulointerstitial injury and glomerular
hemodynamics in hyperuricemia
Tubulointerstitial scarring, glomerulosclerosis, and
vascular disease are prominent findings in renal injury
associated with hyperuricemia and gout [18, 36, 37]. Re-
cently, Mazzali et al [18] reported an experimental model
of mild hyperuricemia in the rat. Administration of oxo-
nic acid mixed in a low-salt diet blocked urate oxidase,
the enzyme responsible for the degradation of uric acid
to allantoin in inferior mammals. This maneuver pro-
duced a slight increment of serum uric acid levels that
were associated with hypertension, and renal damage
characterized by tubulointerstitial inflammatory infiltra-
tion without urate crystal deposition; in addition, there
was overexpression of osteopontin, collagen III, and re-
nin overexpression in juxtaglomerular cells [18]. Hyper-
uricemia also induced medial vascular thickening of the
preglomerular vessels that occurred independent of
blood pressure but was partially dependent of RAS [37].
In cultured vascular smooth muscle cells (VSMCs) uric
acid induced the expression of chemotactic cytokines
[monocyte chemoattractant protein-1 (MCP-1)], oxida-
tive stress, and stimulated proliferation mediated by
platelet-derived growth factor (PDGF) A [38] [abstract;
Kanellis J, et al: J Am Soc Nephrol 13:60A, 2002; Susumu
W, et al: J Am Soc Nephrol 13:514A, 2002).
To further evaluate the impact of tubulointerstitial
injury and arteriolopathy of afferent arterioles on glo-
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merular hemodynamics we studied rats with oxonic acid–
induced mild hyperuricemia [39]. We found that rats
treated with oxonic acid plus low-salt diet developed
hyperuricemia, arterial hypertension, and significant ele-
vation of intraglomerular pressure. Morphometric analy-
sis reveled arteriolopathy of preglomerular vessels indi-
cated by increased arteriolar area and media/lumen ratio.
Simultaneous treatment with allopurinol prevented the
rise in serum uric acid, arterial and glomerular hyperten-
sion, as well as arteriolopathy of afferent arterioles.
Within individual rats there was a striking correlation
between serum uric acid, arteriolar thickening, and sys-
temic blood pressure with glomerular hydrostatic pres-
sure [39]. Moreover, in 5/6 Nx rats, hyperuricemia wors-
ens the course of renal damage progression mediated by
increasing the rise of blood pressure, proteinuria, renal
hypertrophy, preglomerular arteriolopathy, fibrosis, and
glomerulosclerosis associated with a greater expression
of renin and cyclooxygenase (COX)-2 [40]. In this regard,
we have found in rats with subtotal renal ablation that
hyperuricemia is related with severe renal vasoconstric-
tion characterized by decreased glomerular plasma flow,
single nephron glomerular filtration rate (GFR), and
elevations in pre- and post-glomerular resistances associ-
ated with increased arteriolar media/lumen ratios and
more tubulointerstitial fibrosis (unpublished observa-
tions). These findings suggest that arteriolar disease may
have contributed to the transmission of the systolic blood
pressure in glomerular capillaries. Proliferation of
VSMCs and increased collagen deposition might be ex-
pected to increase rigidity of the vascular wall and thus
limit its capacity to contract in response to higher perfu-
sion pressure.
Tubulointerstitial injury and glomerular
hemodynamics in albumin overload
Systemic protein overload (AO) in rats is character-
ized by marked proteinuria and tubulointerstitial (TI)
infiltration of macrophages and T lymphocytes [19–24].
There is increased expression of MCP-1 and trans-
forming growth factor- (TGF-) [19], production of
regulated upon activation, normal T cell expressed and
secreted (RANTES) [22], interleukin (IL)-8 [41], and
tubular activation of NF-B [21–23]. In addition, cells
producing Ang II and reactive oxygen species (ROS)
are present [24] and up-regulation of angiotensinogen
and angiotensin-converting enzyme has been demon-
strated, suggesting an increase in intrarenal generation
of Ang II [20, 21]. Contrasting with the tubulointerstitial
lesions, protein overload is associated with relatively mi-
nor glomerular changes [24]. Thus, this experimental
model seems appropriate to evaluate the alterations of
glomerular hemodynamics associated with tubulointer-
stitial injury. Increased production of Ang II [20, 21],
ROS [24], and other vasoactive molecules [21] can induce
changes in glomerular hemodynamics and impair per-
mselectivity of the capillary wall, thereby contributing
to the enhancement of proteinuria and renal damage.
We recently performed micropuncture (MP) studies
in rats with mild albumin overload. Male Sprague-Daw-
ley rats received 1 g/day of bovine serum albumin intra-
peritoneally for two weeks. Systolic blood pressure in-
creased slightly and urine protein excretion rose by
almost 7-fold (P  0.05); this was associated with renal
cortical vasoconstriction indicated by a decrease in GFR
(27%, P  0.01), single nephron GFR (34%, P 
0.001), and glomerular plasma flow (30%, P  0.01).
Despite this vasoconstrictive response, there was a sig-
nificant rise of 5 mm Hg in glomerular pressure (P 
0.05) that positively correlated with efferent resistance
(r 0.58, P 0.02); afferent resistance increased by 65%
(P  0.01). Histologic examination showed diffuse, mild
tubulointerstitial inflammatory infiltration, and mesangial
expansion in 24% of glomeruli, as well as mild arteriolo-
pathy (Fig. 1). Morphometric analysis of preglomerular
vessels stained with alfa actin–specific antibody showed
a significant increase in media/lumen ratio. Cortical vaso-
constriction and glomerular hypertension were probably
mediated by local release of vasoactive factors by infil-
trating inflammatory cells. Our results suggest that glo-
merular hypertension develops when histologic changes
are still incipient and contribute to perpetuate renal in-
jury associated with proteinuria.
The studies previously described suggest a close rela-
tionship between the inflammatory process, arteriolopa-
thy, and glomerular hemodynamics (Table 1). Local re-
lease of cytokines, growth factors, vasoactive molecules,
and free oxygen radicals, can contribute to development
of arteriolar hypertrophy and increased transmission of
systemic pressure to glomerular capillaries. Prevention
of inflammatory cells infiltration with PPS [31] and with
MMF [35] restores arteriolar structure and function, nor-
malizing glomerular pressure despite persisting systemic
hypertension. Moreover, in experimental CsA nephro-
toxicity, Yang et al [42] recently showed that ameliora-
tion of tubulointerstitial inflammation and fibrosis by
MMF treatment decreased arteriolopathy of afferent ar-
terioles and improved renal function [42]. In oxonic acid–
induced hyperuricemia, mild tubulointerstitial lesions
are associated with arteriolopathy and glomerular hyper-
tension [39]. In albumin overload, proteinuria is associ-
ated with over-expression of chemotactic factors [19, 22,
41], influx of inflammatory cells, and activation of intra-
renal RAS [19–24]. Despite relatively minor glomerular
alterations [24], there is mild arteriolopathy and glomer-
ular hypertension.
The association of afferent arteriolopathy and glomer-
ular hypertension has been demonstrated in the fawn-
hooded rats. This strain constitutes a spontaneous model
for chronic renal failure with early systemic and glomeru-
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Fig. 1. (A ) Tubulointerstitial inflammatory cells infiltrate and (B ) arteriolopathy of afferent arteriole in a rat with albumin overload (1 g/day)
during two weeks.
Table 1. Glomerular hemodynamics, arteriolopathy, and tubulointerstitial inflammation
Model MAP Pgc SNGFR M/L TI MØs Reference
5/6 Nx ↑↑↑ ↑↑↑ ↑↑ ↑↑↑ ↑↑↑ KI 63:994, 2003
5/6 Nx  MMF ↑↑ N ↑ N ↑ KI 63:994, 2003
Low-salt diet ↑ N ↓ N ↑ AJP 283:F1105, 2002
Hypertens 38:1101, 2002
Low-salt diet  OA ↑↑ ↑↑ ↓ ↑↑ ↑↑ AJP 283:F1105, 2002
Hypertens 38:1101, 2002
Normal condition N N N N N AJP 283:F1132, 2002
Albumin overload ↑ ↑ ↓ ↑ ↑↑ AJP 283:F1132, 2002
Abbreviations are: OA, oxonic acid; Alb, albumin; MMF, mycophenolate mofetil; Nx, nephrectomy; N, normal; MAP, mean arterial pressure; Pgc, glomerular
capillary pressure; TI, tubulointerstitial; MØs, macrophages; SNGFR, single nephron glomerular filtration rate; M/L, media to lumen ratio.
lar hypertension [43]. Elevations in renal blood flow,
GFR, and glomerular capillary pressure precede the de-
velopment of renal damage [44]. Arteriolopathy of the
preglomerular vessels is characterized by media hyper-
trophy, coincidental with myocyte degeneration of the
innermost media layers [45]. Glomerular pressure is re-
lated to arterial pressure, indicating that in these rats the
mechanism to maintain constancy of Pgc is less effective,
exposing glomerular capillaries directly to variations in
systemic blood pressure [46]. Although tubulointerstitial
injury has not been studied in this strain, significant le-
sions can be anticipated because of the high levels of
proteinuria exhibited by these animals.
Spontaneous hypertensive rats are relatively resistant
to develop renal lesions; however, one-year-old animals
have proteinuria, glomerular injury, and impaired renal
function [47]. Glomerular hypertension is associated
with reduced glomerular plasma flow and increased af-
ferent and efferent resistances. Histologic examination
revealed glomerular sclerosis, interstitial inflammatory
cells infiltration, and thickening of the afferent arteriolar
wall with proliferation of VSMCs [48]. Thus, although
afferent resistance increased it was insufficient to prevent
the transmission of systemic hypertension to glomerular
capillaries.
The mechanism by which vascular hypertrophy impairs
the ability of preglomerular vessels to limit the transmis-
sion of systemic pressure to glomerular capillaries may
be associated with inflammation of the vascular wall.
Activation of transcription factors, NF-B, and activator
protein-1 (AP-1) in VSMCs induces a switch of VSMCs
to a proliferative phenotype [48]. This change promotes
growth, and increased synthesis and rearrangement of
extracellular matrix proteins, and decreases the synthesis
of contractile proteins, which in turn impair decrease the
response of VSMCs to contractile stimulus [49].
However, in the long term, further hypertrophy of
VSMCs and expanded extracellular matrix (ECM) on
the vascular wall may critically reduce the lumen of pre-
glomerular vessels, inducing the decline of blood flow
to glomeruli and post-glomerular ischemia. Renal hypo-
perfusion stimulates renin secretion and angiotensin II
production, eliciting vasoconstriction of efferent arteri-
oles; this tends to preserve the GFR by further increasing
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Fig. 2. Initial insult to the kidney results in decreased number of neph-
rons that compensate renal function loss by increasing filtration and
glomerular capillary pressure. Glomerular hypertension induces a me-
chanical damage to capillary wall and increases filtration of proteins to
tubular lumen, leading to increased tubular reabsorption that results
in the synthesis of proinflammatory and profibrotic factors. Recruitment
of immune cells amplifies the inflammatory process, inducing hypertro-
phy and proliferation of pre-glomerular vascular smooth muscle cells.
Arteriolopathy results in a maladaptive function that permits the trans-
mission of systemic hypertension to glomerular capillaries. In addition,
inflammation contributes to glomerulosclerosis and tubulointerstitial
fibrosis, further reducing functional nephrons and thereby perpetuating
progression. In conditions in which there is overactivity of the renin-
angiotensin system (RAS) such as hypertension, hyperuricemia, and
albumin overload, arteriolopathy is associated with increased glomeru-
lar pressure and reduced glomerular plasma flow, resulting in post-
glomerular ischemia and tubulointerstitial fibrosis that further contrib-
utes to loss of functioning nephrons.
glomerular hypertension. Post-glomerular ischemia is a
well-known stimulus to produce tubulointerstitial fibro-
sis [50]. The process is self-perpetuating, as ischemia
promotes inflammation and fibrosis, and the loss of glo-
merular and peritubular capillaries induced by fibrosis
aggravates ischemia [51]. Pre-glomerular arteriolopathy
coexisting with loss of glomerular and peritubular capil-
laries was documented in remnant kidney model [52],
nitric oxide inhibition [52], and concomitant hyperuri-
cemia exacerbated these vascular changes [40].
CONCLUSION
Figure 2 illustrates our proposal for the role of arte-
riolopathy in the progression of renal injury as follows:
initial insult to the kidney results in decreased number
of nephrons that compensate renal function loss by in-
creasing filtration and glomerular capillary pressure. On
one hand, glomerular hypertension induces a mechanical
damage to the capillary wall, and on the other hand, it
increases filtration of proteins to tubular lumen, leading
to increased tubular reabsorption that result in the syn-
thesis of proinflammatory and profibrotic factors. Re-
cruitment of immune cells amplifies the inflammatory
process, inducing hypertrophy and proliferation of pre-
glomerular VSMCs. Arteriolopathy results in a maladap-
tive function that permits the transmission of systemic
hypertension to glomerular capillaries. In addition, in-
flammation contributes to glomerulosclerosis and tubu-
lointerstitial fibrosis, further reducing functional neph-
rons and thereby perpetuating progression.
In conditions in which there is overactivity of the RAS,
such as hypertension, hyperuricemia, and albumin over-
load, arteriolopathy is associated with increased glomer-
ular pressure and reduced glomerular plasma flow that
results in post-glomerular ischemia and tubulointerstitial
fibrosis, which further contributes to loss of functioning
nephrons.
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